Author： Yalin Serkan
Publisher： Springer Publishing Company
ISSN： 2210-7703
Source： International Journal of Clinical Pharmacy, Vol.35, Iss.3, 2013-06, pp. : 306-308
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Current Management of Mantle Cell Lymphoma
By Weigert Oliver Unterhalt Michael Hiddemann Wolfgang Dreyling Martin
Drugs, Vol. 67, Iss. 12, 2007-01 ,pp. :
Access to resources
Recommend
Novel therapeutic targets in mantle cell lymphoma
By Martin Peter Leonard John P
Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 7, 2007-07 ,pp. :
Temsirolimus: In Relapsed and/or Refractory Mantle Cell Lymphoma
By Hoy Sheridan M. McKeage Kate
Drugs, Vol. 70, Iss. 14, 2010-10 ,pp. :
Current Status of Targeted Therapies for Mantle Cell Lymphoma
By Chang Julie E. Kahl Brad S.
Drugs, Vol. 71, Iss. 17, 2011-12 ,pp. :
Vincristine: Laryngeal paralysis in children: 4 case reports
Reactions Weekly, Vol. 1, Iss. 1242, 2009-01 ,pp. :